{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:55:24Z","timestamp":1777452924994,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1743-422x-11-149","type":"journal-article","created":{"date-parts":[[2014,8,20]],"date-time":"2014-08-20T07:04:43Z","timestamp":1408518283000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Chitosan microparticles loaded with yeast-derived PCV2 virus-like particles elicit antigen-specific cellular immune response in mice after oral administration"],"prefix":"10.1186","volume":"11","author":[{"given":"Sergio A","family":"Bucarey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myriam","family":"Pujol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joaqu\u00edn","family":"Poblete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia V","family":"Tapia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00f3nico","family":"Neira-Carrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonat\u00e1n","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Bassa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,8,20]]},"reference":[{"key":"2478_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.virusres.2011.09.041","volume":"164","author":"NM Beach","year":"2012","unstructured":"Beach NM, Meng XJ: Efficacy and future prospects of commercially available and experimental vaccines against porcine circovirus type 2 (PCV2). Virus Res 2012, 164: 33-42. 10.1016\/j.virusres.2011.09.041","journal-title":"Virus Res"},{"key":"2478_CR2","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1365-2567.2005.02165.x","volume":"115","author":"IE Vincent","year":"2005","unstructured":"Vincent IE, Carrasco CP, Guzylack-Piriou L, Herrmann B, McNeilly F, Allan GM, Summerfield A, McCullough KC: Subset-dependent modulation of dendritic cell activity by circovirus type 2. Immunology 2005, 115: 388-398. 10.1111\/j.1365-2567.2005.02165.x","journal-title":"Immunology"},{"key":"2478_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.vetmic.2003.10.013","volume":"98","author":"JC Harding","year":"2004","unstructured":"Harding JC: The clinical expression and emergence of porcine circovirus 2. Vet Microbiol 2004, 98: 131-135. 10.1016\/j.vetmic.2003.10.013","journal-title":"Vet Microbiol"},{"key":"2478_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1079\/AHR2005106","volume":"6","author":"J Segales","year":"2005","unstructured":"Segales J, Allan GM, Domingo M: Porcine circovirus diseases. Anim Health Res Rev 2005, 6: 119-142. 10.1079\/AHR2005106","journal-title":"Anim Health Res Rev"},{"key":"2478_CR5","first-page":"1536","volume-title":"Proceedings of the AASV Congress","author":"BWW Tacker","year":"2008","unstructured":"Tacker BWW, Francisco C, Schlueter R: Circumvent PCV vaccine: performance evaluation and serological studies update. Proceedings of the AASV Congress 2008, 1536-1548."},{"key":"2478_CR6","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.prevetmed.2010.11.015","volume":"98","author":"CS Kristensen","year":"2011","unstructured":"Kristensen CS, Baadsgaard NP, Toft N: A meta-analysis comparing the effect of PCV2 vaccines on average daily weight gain and mortality rate in pigs from weaning to slaughter. Prev Vet Med 2011, 98: 250-258. 10.1016\/j.prevetmed.2010.11.015","journal-title":"Prev Vet Med"},{"key":"2478_CR7","doi-asserted-by":"publisher","first-page":"5781","DOI":"10.1016\/j.vaccine.2009.07.061","volume":"27","author":"SA Bucarey","year":"2009","unstructured":"Bucarey SA, Noriega J, Reyes P, Tapia C, Saenz L, Zuniga A, Tobar JA: The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts. Vaccine 2009, 27: 5781-5790. 10.1016\/j.vaccine.2009.07.061","journal-title":"Vaccine"},{"key":"2478_CR8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.vaccine.2011.11.003","volume":"30","author":"V Pavot","year":"2012","unstructured":"Pavot V, Rochereau N, Genin C, Verrier B, Paul S: New insights in mucosal vaccine development. Vaccine 2012, 30: 142-154. 10.1016\/j.vaccine.2011.11.003","journal-title":"Vaccine"},{"key":"2478_CR9","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1517\/17425247.3.6.747","volume":"3","author":"EC Lavelle","year":"2006","unstructured":"Lavelle EC, O\u2019Hagan DT: Delivery systems and adjuvants for oral vaccines. Expet Opin Drug Deliv 2006, 3: 747-762. 10.1517\/17425247.3.6.747","journal-title":"Expet Opin Drug Deliv"},{"key":"2478_CR10","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/S0264-410X(02)00686-2","volume":"21","author":"IM van der Lubben","year":"2003","unstructured":"van der Lubben IM, Kersten G, Fretz MM, Beuvery C, Coos Verhoef J, Junginger HE: Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice. Vaccine 2003, 21: 1400-1408. 10.1016\/S0264-410X(02)00686-2","journal-title":"Vaccine"},{"key":"2478_CR11","first-page":"6077","volume":"7","author":"MA Islam","year":"2012","unstructured":"Islam MA, Firdous J, Choi YJ, Yun CH, Cho CS: Design and application of chitosan microspheres as oral and nasal vaccine carriers: an updated review. Int J Nanomedicine 2012, 7: 6077-6093.","journal-title":"Int J Nanomedicine"},{"key":"2478_CR12","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1517\/17425247.2012.697455","volume":"9","author":"I Jabbal-Gill","year":"2012","unstructured":"Jabbal-Gill I, Watts P, Smith A: Chitosan-based delivery systems for mucosal vaccines. Expet Opin Drug Deliv 2012, 9: 1051-1067. 10.1517\/17425247.2012.697455","journal-title":"Expet Opin Drug Deliv"},{"key":"2478_CR13","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/S0753-3322(01)00073-7","volume":"55","author":"H Le Buanec","year":"2001","unstructured":"Le Buanec H, Vetu C, Lachgar A, Benoit MA, Gillard J, Paturance S, Aucouturier J, Gane V, Zagury D, Bizzini B: Induction in mice of anti-Tat mucosal immunity by the intranasal and oral routes. Biomed Pharmacother 2001, 55: 316-320. 10.1016\/S0753-3322(01)00073-7","journal-title":"Biomed Pharmacother"},{"key":"2478_CR14","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3109\/10611860108995631","volume":"9","author":"IM Van Der Lubben","year":"2001","unstructured":"Van Der Lubben IM, Konings FA, Borchard G, Verhoef JC, Junginger HE: In vivo uptake of chitosan microparticles by murine Peyer\u2019s patches: visualization studies using confocal laser scanning microscopy and immunohistochemistry. J Drug Target 2001, 9: 39-47. 10.3109\/10611860108995631","journal-title":"J Drug Target"},{"key":"2478_CR15","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1080\/1061186021000038319","volume":"10","author":"IM van der Lubben","year":"2002","unstructured":"van der Lubben IM, van Opdorp FA, Hengeveld MR, Onderwater JJ, Koerten HK, Verhoef JC, Borchard G, Junginger HE: Transport of chitosan microparticles for mucosal vaccine delivery in a human intestinal M-cell model. J Drug Target 2002, 10: 449-456. 10.1080\/1061186021000038319","journal-title":"J Drug Target"},{"key":"2478_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/10408410902753746","volume":"35","author":"S Soltanian","year":"2009","unstructured":"Soltanian S, Stuyven E, Cox E, Sorgeloos P, Bossier P: Beta-glucans as immunostimulant in vertebrates and invertebrates. Crit Rev Microbiol 2009, 35: 109-138. 10.1080\/10408410902753746","journal-title":"Crit Rev Microbiol"},{"key":"2478_CR17","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/87974","volume":"7","author":"AC Stubbs","year":"2001","unstructured":"Stubbs AC, Martin KS, Coeshott C, Skaates SV, Kuritzkes DR, Bellgrau D, Franzusoff A, Duke RC, Wilson CC: Whole recombinant yeast vaccine activates dendritic cells and elicits protective cell-mediated immunity. Nat Med 2001, 7: 625-629. 10.1038\/87974","journal-title":"Nat Med"},{"key":"2478_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.vetimm.2008.10.311","volume":"128","author":"E Stuyven","year":"2009","unstructured":"Stuyven E, Cox E, Vancaeneghem S, Arnouts S, Deprez P, Goddeeris BM: Effect of beta-glucans on an ETEC infection in piglets. Vet Immunol Immunopathol 2009, 128: 60-66. 10.1016\/j.vetimm.2008.10.311","journal-title":"Vet Immunol Immunopathol"},{"key":"2478_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1128\/CVI.00344-09","volume":"17","author":"E Stuyven","year":"2010","unstructured":"Stuyven E, Verdonck F, Van Hoek I, Daminet S, Duchateau L, Remon JP, Goddeeris BM, Cox E: Oral administration of beta-1,3\/1,6-glucan to dogs temporally changes total and antigen-specific IgA and IgM. Clin Vaccine Immunol 2010, 17: 281-285. 10.1128\/CVI.00344-09","journal-title":"Clin Vaccine Immunol"},{"key":"2478_CR20","first-page":"47","volume":"11","author":"G Zanello","year":"2009","unstructured":"Zanello G, Meurens F, Berri M, Salmon H: Saccharomyces boulardii effects on gastrointestinal diseases. Curr Issues Mol Biol 2009, 11: 47-58.","journal-title":"Curr Issues Mol Biol"},{"key":"2478_CR21","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1128\/JVI.80.7.3487-3494.2006","volume":"80","author":"G Misinzo","year":"2006","unstructured":"Misinzo G, Delputte PL, Meerts P, Lefebvre DJ, Nauwynck HJ: Porcine circovirus 2 uses heparan sulfate and chondroitin sulfate B glycosaminoglycans as receptors for its attachment to host cells. J Virol 2006, 80: 3487-3494. 10.1128\/JVI.80.7.3487-3494.2006","journal-title":"J Virol"},{"key":"2478_CR22","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1208\/s12249-013-9965-x","volume":"14","author":"JS Choi","year":"2013","unstructured":"Choi JS, Kim Y, Kang J, Jeong SY, Yoo HS: Electrospun chitosan microspheres for complete encapsulation of anionic proteins: controlling particle size and encapsulation efficiency. AAPS PharmSciTech 2013, 14: 794-801. 10.1208\/s12249-013-9965-x","journal-title":"AAPS PharmSciTech"},{"key":"2478_CR23","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0142-9612(00)00231-3","volume":"22","author":"IM van der Lubben","year":"2001","unstructured":"van der Lubben IM, Verhoef JC, van Aelst AC, Borchard G, Junginger HE: Chitosan microparticles for oral vaccination: preparation, characterization and preliminary in vivo uptake studies in murine Peyer\u2019s patches. Biomaterials 2001, 22: 687-694. 10.1016\/S0142-9612(00)00231-3","journal-title":"Biomaterials"},{"key":"2478_CR24","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/nri1728","volume":"5","author":"S Mitragotri","year":"2005","unstructured":"Mitragotri S: Immunization without needles. Nat Rev Immunol 2005, 5: 905-916. 10.1038\/nri1728","journal-title":"Nat Rev Immunol"},{"key":"2478_CR25","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1016\/j.biomaterials.2013.11.073","volume":"35","author":"T Jiang","year":"2014","unstructured":"Jiang T, Singh B, Li HS, Kim YK, Kang SK, Nah JW, Choi YJ, Cho CS: Targeted oral delivery of BmpB vaccine using porous PLGA microparticles coated with M cell homing peptide-coupled chitosan. Biomaterials 2014, 35: 2365-2373. 10.1016\/j.biomaterials.2013.11.073","journal-title":"Biomaterials"},{"key":"2478_CR26","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1021\/mp200598j","volume":"9","author":"S Dunnhaupt","year":"2012","unstructured":"Dunnhaupt S, Barthelmes J, Rahmat D, Leithner K, Thurner CC, Friedl H, Bernkop-Schnurch A: S-protected thiolated chitosan for oral delivery of hydrophilic macromolecules: evaluation of permeation enhancing and efflux pump inhibitory properties. Mol Pharm 2012, 9: 1331-1341.","journal-title":"Mol Pharm"},{"key":"2478_CR27","first-page":"107","volume":"313","author":"RD Gietz","year":"2006","unstructured":"Gietz RD, Woods RA: Yeast transformation by the LiAc\/SS Carrier DNA\/PEG method. Methods Mol Biol 2006, 313: 107-120.","journal-title":"Methods Mol Biol"},{"key":"2478_CR28","volume-title":"Antibodies: A Laboratory Manual","author":"D Harlow EaL","year":"1998","unstructured":"Harlow EaL D: Antibodies: A Laboratory Manual. New York: Cold Spring Harbor Laboratory; 1998."},{"key":"2478_CR29","first-page":"e2259","volume":"44","author":"BJ Quah","year":"2010","unstructured":"Quah BJ, Parish CR: The use of carboxyfluorescein diacetate succinimidyl ester (CFSE) to monitor lymphocyte proliferation. J Vis Exp 2010, 44: e2259.","journal-title":"J Vis Exp"},{"key":"2478_CR30","first-page":"431","volume":"53","author":"GC Dulac","year":"1989","unstructured":"Dulac GC, Afshar A: Porcine circovirus antigens in PK-15 cell line (ATCC CCL-33) and evidence of antibodies to circovirus in Canadian pigs. Can J Vet Res 1989, 53: 431-433.","journal-title":"Can J Vet Res"},{"key":"2478_CR31","first-page":"44","volume":"36","author":"PD Salguero Erica","year":"2007","unstructured":"Salguero Erica PD, Ang\u00e9lica M, Gabriela D: Quantification by flow cytometry of CD4+, CD8+, CD19+ and CD14+ mouse splenocytes, obtained from four species used in Immunotoxicology\u2019s studies. Rev Col Cienc Qu\u00edm Farm 2007, 36: 44-54.","journal-title":"Rev Col Cienc Qu\u00edm Farm"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-11-149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T22:01:14Z","timestamp":1548108074000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-11-149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,20]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2478"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-11-149","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,20]]},"assertion":[{"value":"13 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"149"}}